Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2000
02/02/2000EP0975977A1 Analysis of molecules
02/02/2000EP0975976A1 Calibrator material for instruments which measure interferents in serum and plasma specimens
02/02/2000EP0975975A1 Method for determining activated coagulation factors in plasma and plasma derivatives
02/02/2000EP0975974A1 Assay utilizing magnetic particles
02/02/2000EP0975973A1 Method for determining the presence of mutated brca protein
02/02/2000EP0975972A1 Methods for identifying cell cycle regulators
02/02/2000EP0975971A1 Methods for detecting cell apoptosis
02/02/2000EP0975970A1 Receptor binding assays and reagent kit for detecting tsh receptor auto-antibodies
02/02/2000EP0975969A1 Methods for screening compounds using encapsulated cells
02/02/2000EP0975968A2 Method for isolating a target biological material, capture phase, detection phase and reagent
02/02/2000EP0975967A1 Sensing system for specific substance and molecule detection
02/02/2000EP0975966A1 Screening for compounds that inhibit phosphorylation of i(kappa)b(alpha)
02/02/2000EP0975965A1 Methods of diagnosing a medically resistant clinical subtype of ulcerative colitis
02/02/2000EP0975964A1 In situ identification of target structures e.g. in vivo selection method for a phage library
02/02/2000EP0975963A1 Prostate specific antigen substrates
02/02/2000EP0975962A1 Drug screen targeting lipoprotein-membrane anchorage
02/02/2000EP0975961A1 Monitoring of dough properties
02/02/2000EP0975960A2 Somatic cell analyser
02/02/2000EP0975959A1 Detection of teratogen exposure
02/02/2000EP0975956A1 Assessing the composition of liquids
02/02/2000EP0975955A2 Methods and systems for sensing water in liquids
02/02/2000EP0975954A1 Use of one-dimensional nuclear magnetic resonance to identify ligands to target biomolecules
02/02/2000EP0975951A1 Moisture detection
02/02/2000EP0975949A1 Device for determining the decay time of compressed medicaments such as tablets and capsules, and corresponding method
02/02/2000EP0975810A1 Method of pcr testing of pooled blood samples
02/02/2000EP0975807A1 Two-step hybridization and capture of a polynucleotide
02/02/2000EP0975805A1 Hybridisation assay in which excess probe is destroyed
02/02/2000EP0975801A1 METHODS FOR SCREENING FOR ANTIMICROBIALS UTILIZING (aarC) AND COMPOSITIONS THEREOF
02/02/2000EP0975800A1 Assaying nucleotides in solution using pna probes
02/02/2000EP0975798A1 Method to diagnose and treat pathological conditions resulting from deficient ion transport such as pseudohypoaldosteronism type-1
02/02/2000EP0975794A1 Method of detecting procarboxypeptidase a and carboxypeptidase a levels in biological fluids
02/02/2000EP0975781A1 Molecular marker for muscle stem cells
02/02/2000EP0975772A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract
02/02/2000EP0975759A1 Human tumor-associated kazal inhibitor
02/02/2000EP0975755A1 Crsp protein (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor
02/02/2000EP0975754A1 Osteoprotegerin binding proteins and receptors
02/02/2000EP0975753A2 $g(b)-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
02/02/2000EP0975752A1 Human cerberus protein
02/02/2000EP0975751A1 A tm4sf human tumor-associated antigen
02/02/2000EP0975747A1 Polypeptide capable of reacting with antibodies of patients suffering from multiple sclerosis and uses
02/02/2000EP0975744A1 Fractional cell sorter
02/02/2000EP0975673A2 Determination of recombinant glycosylated proteins and peptides in biological fluids
02/02/2000EP0975668A1 MODIFIED TNF$g(a) MOLECULES, DNA ENCODING SUCH MODIFIED TNF$g(a) MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNF$g(a) MOLECULES AND DNA
02/02/2000EP0975667A1 METHODS OF DIAGNOSING CLINICAL SUBTYPES OF CROHN'S DISEASE WITH CHARACTERISTIC RESPONSIVENESS TO ANTI-Th1 CYTOKINE THERAPY
02/02/2000EP0975666A2 Compositions and methods for the treatment and diagnosis of breast cancer
02/02/2000EP0975663A1 Helicobacter pylori antigens
02/02/2000EP0975651A1 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease
02/02/2000EP0975429A4 A centrifuge apparatus with temperature control means
02/02/2000EP0975429A1 A centrifuge apparatus with temperature control means
02/02/2000EP0975427A1 A device for performing an assay, a method for manufacturing said device, and use of a membrane in the manufacture of said device
02/02/2000EP0975361A1 Methods of modulating immune coagulation
02/02/2000EP0975355A2 Hexameric fusion proteins and uses therefor
02/02/2000EP0912223A4 Microfabricated filter and shell constructed with a permeable membrane
02/02/2000EP0809509A4 Allosteric control of nuclear hormone receptors
02/02/2000EP0729580B1 Method of identifying hdm-2-specific antibodies
02/02/2000EP0695420B1 Monitoring soil compaction
02/02/2000EP0689672B1 An optical arrangement for flow cytometers
02/02/2000EP0656117B1 A methodology for selecting superagonists, antagonists and superantagonists of interleukin 6
02/02/2000EP0584136B1 Determination of motifs of peptides on mhc molecules
02/02/2000EP0397834B1 Method for identifying active domains and amino acid residues in polypeptides and hormone variants
02/02/2000CN2362127Y Device for monitoring and diagnosing steamwater quality in thermodynamic equipment of power station
02/02/2000CN2362126Y Device for monitoring running status of polution treatment equipment set
02/02/2000CN2362125Y Dropping device for leakage tracking tester
02/02/2000CN1243575A Method and apparatus for conducting stable isotope measure using spectroscope
02/02/2000CN1243445A Photochemotherapeutic compositions
02/02/2000CN1243251A Method for separating red blood cells and blood serum and whole blood immunologic function test reagent
02/02/2000CN1243248A Substrate quantitative determining method and determining apparatus thereof
02/02/2000CN1242937A Method for killing AIDS virus in blood product by using photosensitization of polycyclic quinone chemical compounds
02/01/2000USRE36547 Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists
02/01/2000US6021339 Urine testing apparatus capable of simply and accurately measuring a partial urine to indicate urinary glucose value of total urine
02/01/2000US6020588 Apparatus for investigating flowable material and device for conveying samples
02/01/2000US6020537 Prion protein standard and method of making same
02/01/2000US6020481 Fluorescent labeling reagents; dideoxy polynucleotide sequencing and fragment analysis methods.
02/01/2000US6020478 Human tumor-associated antigen
02/01/2000US6020473 Nucleic acids encoding variants of vascular endothelial cell growth factor
02/01/2000US6020468 Antibodies directed against binding-associated epitopes
02/01/2000US6020466 Myeloid cell leukemia associated gene mcl-1
02/01/2000US6020463 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target
02/01/2000US6020462 Nucleic acids encoding the hypoxia inducible factor-1
02/01/2000US6020312 Synthetic antibiotics
02/01/2000US6020310 Method for assisting in differential diagnosis and treatment of autistic syndromes
02/01/2000US6020306 Receptor-type tyrosine kinase and use thereof
02/01/2000US6020212 Phycobiliprotein-linker peptide complex fluorescent tracer and methods of using the same
02/01/2000US6020211 Separation of magnetic microparticles involving a preconcentration step
02/01/2000US6020210 Methods and materials for high gradient magnetic separation of biological materials
02/01/2000US6020209 Microcapillary-based flow-through immunosensor and displacement immunoassay using the same
02/01/2000US6020208 Systems for surface-enhanced affinity capture for desorption and detection of analytes
02/01/2000US6020206 Homocysteine assay
02/01/2000US6020203 Boronate affinity high pressure liquid chromatographic column comprising hydroxyboryl moeities bound on a support
02/01/2000US6020195 Antibodies against hepatitis G virus and their use for the diagnostic detection of HGV and as a therapeutic agent
02/01/2000US6020192 Genes adapted for high level expression in mammalian cells, especially those of human origin.
02/01/2000US6020182 Subunit respiratory syncytial virus vaccine preparation
02/01/2000US6020181 Inhibition of thrombus formation by medical related apparatus comprising treating with fibrinolytic matrix metalloproteinase
02/01/2000US6020170 Method of preparing a monoclonal antibody
02/01/2000US6020165 Cytikine signal regulators
02/01/2000US6020157 Polynucleotides encoding HFGAN72X receptor
02/01/2000US6020153 Chimeric antibodies
02/01/2000US6020152 Lymphocyte-associated cell surface protein
02/01/2000US6020148 In vitro method for eye and skin irritation testing
02/01/2000US6020147 Chemical analysis apparatus and method